Table 2

Clinical descriptions of patients receiving CDT

AgeGenderAdmission oxygen requirementPE category (ESC) ClassificationDVTCDT*Survival to dischargeISTH major bleedingDischarge location
78FemaleBiPAPIntermediate highNoBilateral 12 mgYesYesSNF
75FemaleNRBIntermediate highYesBilateral 16 mgNoNoDeceased
84Female4 L/minIntermediate highYesUnilateral 20mgYesNoSNF
79Female6 L/minIntermediate highYesBilateral 12 mgYesNoHome
77Female10 L/minIntermediate highNoUnilateral6mgYesNoHome
73Male6 L/minIntermediate highYesBilateral; 12 mgYesNoHome
73Female4 L/minIntermediate highYesBilateral 12 mgYesNoHome
69Female0 L/minIntermediate highYesBilateral 12 mgYesNoHome
68Female0 L/minIntermediate highNoBilateral 12 mgYesNoHome
67Male0 L/minIntermediate highYesBilateral 24 mgYesNoHome
66Male0 L/minIntermediate highNoBilateral 24 mgYesNoHome
65Male0 L/minIntermediate highBilateral 24 mgYesNoHome
66Female2 L/minIntermediate highYesBilateral 12 mgYesNoHome
71Male2 L/minIntermediate highYesBilateral 12 mgYesNoHome
76Male3 L/minIntermediate highYesBilateral 24 mgYesNoHome
76Female0 L/minIntermediate highNoBilateral 12 mgYesNoSNF
83Male2 L/minIntermediate highNoBilateral 12 mgNoNoDeceased
83Male2 L/minIntermediate highYesUnilateral 6 mgYesNoSNF
  • *CDT details: unilateral versus bilateral catheter placement in the pulmonary artery catheters and total tPA dose.

  • BIPAP, bilevel positive airway pressure; CDT, catheter directed thrombolysis; DVT, deep vein thrombosis; ESC, European Society of Cardiology; ISTH, International Society on Thrombosis and Hemostasis; NRB, non-rebreather; PE, pulmonary embolism; SNF, skilled nursing facility; tPA, tissue plasminogen activator.